首頁 > 市場調查報告書 > 製藥

生物標記循環系統

市場調查報告書

商品編碼

1672758

心臟生物標記市場按產品類型、應用、測試地點和地區分類

Cardiac Biomarkers Market, By Product Type, By Application, By Location of Testing, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球心臟生物標記市場規模估計為 171.4 億美元，預計到 2032 年將達到 416.2 億美元，2025 年至 2032 年的複合年成長率為 13.5%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	171.4億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	13.50％	2032 年金額預測	416.2億美元

圖。

心臟生物標記是心肌受傷或受壓時血液中存在的蛋白質。它有助於檢測和監測各種心臟疾病。由於心血管疾病發病率不斷上升以及全球易患心臟病的老年人口增加，心臟生物標記市場在過去幾年中經歷了顯著成長。此外，技術的進步正在推動敏感生物標記的開發，從而能夠早期發現心臟病。

市場動態

全球心臟生物標記市場受到人口老化加劇、心血管疾病經濟負擔加重、就地檢驗應用日益廣泛以及持續研發的推動。然而，核准新的心臟生物標記的監管挑戰、缺乏認知以及不願接受新技術對市場參與企業構成了挑戰。由於醫療支出不斷增加、糖尿病和文明病負擔加重以及本土參與企業的湧現，新興經濟體被視為提供了市場機會。主要參與企業致力於開發新型生物標記面板和可攜式測試設備，以改善患者的監測和管理。

研究的主要特點

本報告對全球心臟生物標記市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球心臟生物標記市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球心臟生物標記市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過全球心臟生物標記市場分析中使用的各種策略矩陣更輕鬆地做出決策。

公司簡介
- Abbott Laboratories
- Life Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Becton, Dickinson and Company（BD）
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation

第 10 章分析師建議

興衰
一致的機會地圖

第 11 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI4576

Global Cardiac Biomarkers Market is estimated to be valued at USD 17.14 Bn in 2025 and is expected to reach USD 41.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 17.14 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	13.50%	2032 Value Projection:	USD 41.62 Bn

Figure. Cardiac Biomarkers Market Share (%), By Region 2025

Cardiac biomarkers refer to proteins that are present in blood when the heart muscle is damaged or stressed. They help detect and monitor various heart conditions. The cardiac biomarkers market has been witnessing significant growth over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of more sensitive biomarkers that can enable the earlier detection of cardiac conditions.

Market Dynamics:

The global cardiac biomarkers market is driven by the increasing geriatric population, rising economic burden of cardiovascular diseases, growing adoption of point-of-care testing, and ongoing research & development. However, regulatory issues regarding the approval of new cardiac biomarkers, lack of awareness, and reluctant acceptance of new technologies pose challenges to market players. The market sees opportunities in developing economies due to increasing healthcare spending, growing diabetes and lifestyle disease burden, and emergence of local players. Key players are focusing on developing novel biomarker panels and portable testing devices for improved patient monitoring and management.

Key Features of the Study:

This report provides an in-depth analysis of the global cardiac biomarkers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cardiac biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, bioMerieux, and Becton, Dickinson and Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cardiac biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac biomarkers market.

Detailed Segmentation-

By Product Type:
- Myocardial Muscle Creatine Kinase (CK MB)
- Myoglobin
- Troponins (T and I)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
By Application:
- Myocardial Infarction 35.5
- Congestive Heart Failure,
- Acute Coronary Syndrome,
- Atherosclerosis,
- Others
- Myocardial Infarction 35.5
- Congestive Heart Failure,
By Location of Testing:
- Laboratory Testing 70.1 %
- Point of Care Testing
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott Laboratories
- Life Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Location of Testing
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Cardiac Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Cardiac Biomarkers Market, By Product Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Myocardial Muscle Creatine Kinase (CK MB)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Myoglobin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn) Myoglobin
Troponins (T and I)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ischemia-modified Albumin (IMA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cardiac Biomarkers Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Myocardial Infarction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Congestive Heart Failure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Acute Coronary Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Atherosclerosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cardiac Biomarkers Market, By Location of Testing, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Laboratory Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Point of Care Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cardiac Biomarkers Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Life Diagnostics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Roche Diagnostics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siemens Healthineers
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Becton, Dickinson and Company (BD)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Rad Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation